Evidence map›Paper›PMID 43011315›Full record

ArticleGut microbiome (Cambridge, England)2026

The gut, conductor of our health: putting the microbiota in the spotlight, a symposium report.

Kaori Suzuki, Nikoletta Vidra, Chiyuki Kajita, Bruno Daniel Frans Pot

Abstract read
In one paragraph

Article in Gut microbiome (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaori SuzukiSkriptory, Netherlands.
Nikoletta VidraScience, Yakult Europe BV, Netherlands.
Chiyuki KajitaScience, Yakult Europe BV, Netherlands.
Bruno Daniel Frans PotScience, Yakult Europe BV, Netherlands.ORCID https://orcid.org/0000-0001-5995-6929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report summarizes key takeaways from the 11th International Yakult Symposium held in Amsterdam, the Netherlands, in October 2024. It provides an overview of insights obtained by the latest basic and clinical research, meta-analyses, and omics research, underscoring the relevance of the exposome, the outer and inner factors to which our bodies are exposed throughout our entire lifespan, in shaping the microbiota. The symposium addressed external factors such as diet (including probiotics and novel fermented foods), additives, pharmacologic agents, and physical environment, as well as the internal crosstalk between tissue or organ-specific microbial communities and their interactions with immune mediators, metabolic and neuroendocrine hormones, and their receptors. Collectively, the data presented during the symposium reinforced the understanding that health and disease are the result of the (im)balance of a tightly interconnected network rather than isolated axes. This was illustrated using examples of inflammatory and infectious diseases of the brain, mouth, gynaecologic tract, lungs, as well as of metabolic and mental states. Finally, a roundtable discussion on the current state of clinical trials in nutrition, including challenges and solutions was featured. The conclusion indicated that there is room for new developments and that hurdles need to be overcome, requiring continued collaboration across scientific disciplines.

Indexed as

exposomefermented foodsgut–brain axisgut–lung axisgut–mouth axisLacticaseibacillus paracasei strain Shirotamicrobiomemicrobiotaprobiotic

Identifiers

PMID43011315
PMCPMC13749102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.